Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersÅslaug Helland, David D.L. Bowtell, Michael S. Anglesio et al.|PLoS ONE|2011Cited by 219
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Simon J. Harrison, John K. C. Lim et al.|Cancer Discovery|2019Cited by 201
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapyEmily J. Lelliott, Karen E. Sheppard|Scientific Reports|2019Cited by 29